Profile
RNTX ONC WBA DFTX HROWL HROWM
Company Name Rein Therapeutics Inc. BeOne Medicines Ltd. Walgreens Boots Alliance, Inc. Definium Therapeutics, Inc. Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 11.875% Senior Notes due 2027
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals
Market Cap $29.97M $37.82B $10.37B $1.64B $1.37B $1.34B
Employees 0.01K 11.00K 193.00K 0.07K 0.22K 0.22K
CEO James Brian Windsor John V. Oyler Timothy C. Wentworth Robert Barrow Mark L. Baum Mark L. Baum
Ratings
RNTX ONC WBA DFTX HROWL HROWM
Quant Rating Score 2 2 2 1 1 1
Quant Rating Sell Sell Sell Strong Sell Strong Sell Strong Sell
Trading
RNTX ONC WBA DFTX HROWL HROWM
Last Close $1.22 $376.63 $11.98 - $25.61 $26.03
High 52 $2.7 $377.81 $12.93 - $25.72 $26.95
Low 52 $1.08 $175.1 $8.24 - $25.01 $25.85
Price vs. 52 Week High -54.81 % -0.31 % -7.35 % - -0.43 % -3.41 %
Price vs. 52 Week Low 12.96 % 115.09 % 45.39 % - 2.4 % 0.7 %
Total Return
RNTX ONC WBA DFTX HROWL HROWM
1 Month Return 0 % 19.03 % 0 % - 0 % 0 %
3 Month Return 7.96 % 17.95 % -0.17 % - 0.55 % -1.33 %
6 Month Return -44.8 % 64.91 % 6.11 % - 1.23 % -0.78 %
9 Month Return -49.06 % 58 % 8.32 % - 1.13 % -2.87 %
YTD Return 0 % 104.69 % 28.4 % - 1.32 % -0.69 %
1 Year Return 0 % 0 % 44.51 % - 1.31 % -1.03 %
3 Year Return 0 % 0 % 0 % - 0 % 0 %
5 Year Return 0 % 0 % 0 % - 0 % 0 %
Dividends
RNTX ONC WBA DFTX HROWL HROWM
Dividend Yield Percentage (TTM) - - - - - -
Dividend Paid and Capex Coverage Ration (TTM) - 2.45 % 0.96 % - 0.46 % 0.46 %
Dividend Per Share (TTM) - - - - - -
Payout Ratio (TTM) - - -10.29 % - - -
Growth
RNTX ONC WBA DFTX HROWL HROWM
Asset Growth -34.68 % 1.99 % -16.14 % 24.77 % 24.77 %
Gross Profit Growth - 54.71 % -2.02 % 66.06 % 66.06 %
Revenue Growth - 54.96 % 6.17 % 53.32 % 53.32 %
Revenue 3 Year - 185.46 % 11.65 % 106.71 % 106.71 %
Revenue 5 Year - 407.52 % 31.29 % 177.12 % 177.12 %
Revenue 10 Year - 14520 % 113.45 % 2980.55 % 2980.55 %
EBIT Growth -183063.93 % 52.95 % -183.88 % 1018.99 % 1018.99 %
Net Income Growth -399613.96 % 26.87 % -180.39 % 28.39 % 28.39 %
Net Income 3 Yeari Growth Per Share -59389.19 % 61.02 % -440.4 % 27.14 % 27.14 %
Net Income 5 Yeari Growth Per Share - 61.23 % -331.55 % -7491.01 % -7491.01 %
Net Income 10 Yeari Growth Per Share - -1664.38 % -593.61 % 55.74 % 55.74 %
Operating Income Growth -399949.15 % 52.95 % -104.53 % 1946.87 % 1946.87 %
Operating Cash Flow Growth (CFG) -12.54 % 87.85 % -54.92 % -678.18 % -678.18 %
Operating 3 Year CFG 76.77 % 90.46 % -81.64 % -427.89 % -427.89 %
Operating 5 Year CFG - 89.31 % -80.57 % -1760.03 % -1760.03 %
Operating 10 Year CFG - -709.03 % -71.12 % 19.39 % 19.39 %
EPS Growth -2.63 % 27.57 % -180.39 % 34.67 % 34.67 %
EPS Diluted Growth -2.63 % 27.57 % -180.39 % 34.67 % 34.67 %
Book Value Per Share 102.44 % -6.6 % -57.24 % -9.43 % -9.43 %
Share Holder 3 Year Equity Growth Per Share -69.34 % -52.12 % -56.07 % 363.19 % 363.19 %
Share Holder 5 Year Equity Growth Per Share - 97.53 % -53.83 % 78.54 % 78.54 %
Share Holder 10 Year Equity Growth Per Share - 6367.84 % -43.9 % 118.93 % 118.93 %
Dividend Per Share Growth - - -24.04 % - -
Dividend 3 Year Growth Per Share - - -21.92 % -100 % -100 %
Dividend 5 Year Growth Per Share - - -18.12 % - -
Dividend 10 Year Growth Per Share - - 16.05 % - -
Debt Growth -100 % 16.09 % 0.7 % 20.12 % 20.12 %
Free Cash Flow Growth -12.54 % 61.81 % -357.45 % 59.06 % 59.06 %
Updated On 31 Dec 2024 31 Dec 2024 31 Aug 2024 31 Dec 2024 31 Dec 2024
Profitability
RNTX ONC WBA DFTX HROWL HROWM
Gross Profit Margin TTM - 86.11 % 17.13 % - 74.56 % 74.56 %
Return on Assets TTM -109.64 % 1.06 % -9.07 % -70.95 % -1.37 % -1.37 %
Return on Equity TTM -217.16 % 2.19 % -70.17 % -86.18 % -8.96 % -8.96 %
Return on Capital Employed TTM -49.56 % 3.06 % -7.17 % -88.16 % 9.35 % 9.35 %
Net Income Per EBT TTM 97.44 % 39.97 % 107.6 % 100 % 90.66 % 90.66 %
EBT Per Ebit TTM 254.23 % 125.31 % 187.84 % 111.18 % -19.78 % -19.78 %
EBIT Per Revenue TTM - 3.2 % -2.02 % - 11.13 % 11.13 %
Cash Flow To Debt Ratio TTM - 77 % 5.43 % - 7.02 % 7.02 %
Receivables Turnover TTM - 5.83 23.42 - 3.21 3.21
Payables Turnover TTM - 1.82 9.41 - 3.35 3.35
Inventory Turnover TTM - 1.31 17.5 - 4.96 4.96
Fixed Asset Turnover TTM - 284.64 % 556.84 % - 2202.82 % 2202.82 %
Asset Turnover TTM - 65.95 % 222.72 % - 68.87 % 68.87 %
Operating Cash Flow Per Share TTM -0.79 7.13 1.82 -1.33 0.48 0.48
Free Cash Flow Per Share TTM -0.79 4.22 0.67 -1.33 -0.55 -0.55
Cash Per Share TTM 15.36 % 3662.7 % 95.96 % 243.43 % 200 % 200 %
Operating Cash Flow Sales Ratio TTM - 15.6 % 1.02 % - 7.07 % 7.07 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 59.15 % 36.78 % 100 % -115.84 % -115.84 %
Cash Flow Coverage Ratios TTM - 77 % 5.43 % - 7.02 % 7.02 %
Price To Free Cash Flows Ratio TTM -1.43 88.39 17.88 -14.42 -85.37 -85.6
Price To Operating Cash Flows Ratio TTM -1.43 5.51 6.57 -12.74 99.18 99.45
Price Cash Flow Ratio TTM -1.43 5.51 6.57 -12.74 99.18 99.45
Income Statement (TTM)
RNTX ONC WBA DFTX HROWL HROWM
Revenue $0B $3.81B $147.66B $0B $0.2B $0.2B
Gross Profit $0B $3.22B $26.52B $-0B $0.15B $0.15B
Gross Profit Ratio 0% 84.41% 17.96% 0% 75.33% 75.33%
EBITDA $-0.03B $-0.4B $-11.28B $-0.11B $0.02B $0.02B
Net Income $-0.06B $-0.64B $-8.64B $-0.11B $-0.02B $-0.02B
EPS Diluted -3.51 -6.12 -10.01 -0.15 -0.49 -0.49
Balance Sheet (MRQ)
RNTX ONC WBA DFTX HROWL HROWM
Long Term Debt $0B $0.21B $29.88B $0.02B $0.23B $0.23B
Total Liabilities $0.01B $2.59B $68.86B $0.06B $0.32B $0.32B
Total Equity $0.05B $3.33B $12.18B $0.24B $0.07B $0.07B
Total Investments $0B $0.13B $4.06B $0B $0B $0B
Total Debt $0B $1.08B $33.77B $0.02B $0.23B $0.23B
Total Assets $0.07B $5.92B $81.04B $0.3B $0.39B $0.39B
Cash Flow Statement (TTM)
RNTX ONC WBA DFTX HROWL HROWM
Net Income $-0.06B $-0.64B $-15.45B $-0.11B $-0.02B $-0.02B
Inventory $0B $-0.09B $-0.03B $0B $0B $0B
Dividends Paid $0B $0B $-1.26B $0B $0B $0B
Operating Cash Flow $-0.02B $-0.14B $1.02B $-0.08B $-0.02B $-0.02B
Capital Expenditure $0B $-0.53B $-1.38B $0B $-0.04B $-0.04B
Related Stocks
Ticker Name Price
AIXC Qualigen Therapeutics, Inc. 1.37
ATAI Atai Life Sciences N.V. 3.86
ATNFW CannBioRx Life Sciences Corp. 0.43
BGMS Bio Green Med Solution, Inc. 1.02
BGMSP Bio Green Med Solution, Inc. 3.73
BIMI BIMI International Medical Inc. 0.0001
CGEM Cullinan Oncology, Inc. 12.21
CJJD China Jo-Jo Drugstores, Inc. 1.52
DFTX Mind Medicine (MindMed) Inc. 17.375
HITI High Tide Inc. 2.37
HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares 0.8239
HROWL Harrow Health, Inc. 8.625% Senior Notes due 2026 25.61
HROWM Harrow Health, Inc. 11.875% Senior Notes due 2027 26.03
KYNB FibroGen, Inc. 7.78
LFLY Leafly Holdings, Inc. 37
LFLYW Leafly Holdings, Inc. 0.004
LFMD LifeMD, Inc. 3.045
LFMDP LifeMD, Inc. 22.4
MDVL MedAvail Holdings, Inc. 1.8
MEDS TRxADE HEALTH, Inc. 7.59
ETFs With Exposure to RNTX
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00004 341.86
VXF Vanguard Extended Market Index Fund 0.00037 219.39
ONEQ Fidelity Nasdaq Composite Index ETF 0 90.93
IWC iShares Micro-Cap ETF 0.00599 169.93
VUN.TO Vanguard U.S. Total Market Index ETF 0.00004 125.89
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0.00004 118.65
VGRO.TO Vanguard Growth ETF Portfolio 0.00002 44.3
VEQT.TO Vanguard All-Equity ETF Portfolio 0.00002 55.73
VBAL.TO Vanguard Balanced ETF Portfolio 0.00001 37.805
VCNS.TO Vanguard Conservative ETF Portfolio 0.00001 32.08
VCIP.TO Vanguard Conservative Income ETF Portfolio 0 27.325
VRIF.TO Vanguard Retirement Income ETF Portfolio 0 26.945
VTSAX Vanguard Total Stock Market Index Fund 0.00004 166.85
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00037 166.55
VITSX Vanguard Total Stock Market Index Fund 0.00004 166.88
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00037 166.56
VTS.AX Vanguard US Total Market Shares Index ETF 0.00004 484.72
VEMPX Vanguard Extended Market Index InstlPlus 0.00037 411.02
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00004 313.05
Unlock